Obesity-associated gut dysbiosis: Metabolic dysfunction-associated steatotic liver disease as a clinical model of host–microbiome interactions

Show simple item record

dc.contributor.author Plakida, A.
dc.contributor.author Moskal, O.
dc.contributor.author Gushcha, S.
dc.date.accessioned 2026-11-15T12:15:29Z
dc.date.available 2026-11-15T12:15:29Z
dc.date.issued 2026
dc.identifier.citation Plakida A., Moskal O., Gushcha S. Obesity-associated gut dysbiosis: Metabolic dysfunction-associated steatotic liver disease as a clinical model of host–microbiome interactions // Microbes & Immunity. 2026. Vol.10, n.10. P. 1-17. doi: 10.36922/MI026270079 uk_UA
dc.identifier.uri https://repo.odmu.edu.ua:443/xmlui/handle/123456789/20583
dc.description.abstract Obesity is associated with profound alterations in the composition and function of the gut microbiota that extend far beyond the gastrointestinal tract. Accumulating evidence indicates that obesity-associated gut dysbiosis influences intestinal barrier integrity, immune regulation, microbial metabolism, and systemic metabolic homeostasis through interconnected biological mechanisms. These alterations contribute to the development of chronic metabolic disorders affecting several organ systems. This review summarizes current knowledge regarding the host– microbiome interactions linking obesity-associated gut dysbiosis with metabolic dysfunction. Particular attention is given to the sequential interactions between microbial ecosystem remodeling, impaired intestinal barrier function, chronic low- grade inflammation, and metabolic disturbances that collectively promote obesity- associated diseases. Rather than focusing exclusively on liver pathology, metabolic dysfunction-associated steatotic liver disease is presented as one of the best- characterized clinical models demonstrating how disturbances originating within the gut microbiome evolve into systemic metabolic disease. Finally, emerging therapeutic strategies targeting the gut–microbiome axis are discussed, with emphasis on restoration of microbial homeostasis and early intervention aimed at interrupting pathophysiological progression before irreversible metabolic complications develop. These approaches may contribute to preventing or attenuating obesity-associated metabolic complications. uk_UA
dc.language.iso en uk_UA
dc.publisher AccScience Publishing en
dc.subject Gut microbiota uk_UA
dc.subject Obesity uk_UA
dc.subject Gut dysbiosis uk_UA
dc.subject Intestinal barrier uk_UA
dc.subject Metabolic dysfunction uk_UA
dc.subject Metabolic dysfunction-associated steatotic liver disease uk_UA
dc.title Obesity-associated gut dysbiosis: Metabolic dysfunction-associated steatotic liver disease as a clinical model of host–microbiome interactions uk_UA
dc.type Article uk_UA


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account